• 1
    The EUROGAST Study Group. Epidemiology and risk factors for H. pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34: 16726.
  • 2
    The EUROGAST Study Group. An international association between H. pylori infection and gastric cancer. Lancet 1993; 341: 135965.
  • 3
    Parsonet J, Hansen S & Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 126771.
  • 4
    Patel P, Khulusi S & Mendall MA, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 13158.
  • 5
    Kosunen TU, Seppala K, Sarna S & Sipponen P. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339: 8935.
  • 6
    Veenendal RA, Pena AS & Meijer JL, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32: 12914.
  • 7
    Cutler A, Schubert A & Schubert T. Role of Helicobacter pylori serology in evaluating treatment success. Dig Dis Sci 1993; 38: 22626.
  • 8
    Savarino V, Vigneri S & Celle G. The C urea breath test in the diagnosis of Helicobacter pylori infection. Gut 1999; 45(Suppl.): I18I22.
  • 9
    Graham DY, Klein PD & Evans DJ, et al. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1987; 23: 11747.
  • 10
    Logan RPH, Polson RJ & Misiewicz JJ, et al. Simplified single sample 13carbon urea breath test for Helicobacter pylori: Comparison with histology, culture and ELISA serology. Gut 1991; 32: 14614.
  • 11
    Van Der Hulst RW, Lamouliatte H & Megraud F, et al. Laser assisted ratio analyser 13C-urea breath testing, for the detection of H. pylori: a prospective diagnostic European multicentre study. Aliment Pharmacol Ther 1999; 13: 11717.DOI: 10.1046/j.1365-2036.1999.00594.x
  • 12
    Hamlet A, Stage L & Lonroth H, et al. A novel tablet-based 13C urea breath test for Helicobacter pylori with enhanced performance during acid suppression therapy. Scand J Gastroenterol 1999; 34: 36774.
  • 13
    Atherton JC & Spiller RC. The urea breath test for Helicobacter pylori. Gut 1994; 35: 7235.
  • 14
    Israeli E, Ilan Y & Sestieri M, et al. Continuous, real time measurement with a novel 13C-breath analyzer: faster urea breath test results with high accuracy. Gastroenterology 1999; 116: A195A195(Abstract).
  • 15
    Rauws EA, Langenberg W & Houthoff HJ, et al. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 3340.
  • 16
    Musgeore C, Bolton FJ & Krypcyk AM, et al. Campylobacter pylori: clinical, histological and serological studies. J Clin Pathol 1988; 41: 131621.
  • 17
    Abdalla AM, Sordillo EM & Hanzely Z, et al. Insensitivity of the CLOtest for H. pylori, especially in the elderly. Gastroenterology 1998; 115: 2434.
  • 18
    Fox JG, Correa P & Taylor NS, et al. Campylobacter pylori- associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol 1989; 84: 77581.
  • 19
    Nedenskov-Sorensen P, Aase S & Bjorneklett A, et al. Sampling efficiency in the diagnosis of H. pylori infection and chronic active gastritis. J Clin Microbiol 1991; 29: 6725.
  • 20
    Goossens H, Glupczynski Y & Burette A, et al. Evaluation of a commercially available second generation immunoglobulin G enzyme immunoassay for detection of H. pylori infection. J Clin Microbiol 1992; 30: 17680.
  • 21
    Thijs JC, Zwet AA & Thijs WJ, et al. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as a gold standard. Am J Gastroenterol 1996; 91: 21259.
  • 22
    Schembri MA, Lin SK & Lambert JR. Comparison of commercial diagnostic kits for H. pylori antibodies. J Clin Microbiol 1993; 31: 26214.
  • 23
    Taha AS, Reid J & Boothmann P, et al. Serological diagnosis of Helicobacter pylori—evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 1993; 34: 4615.
  • 24
    Moayyedi P, Carter AM & Catto A, et al. Validation of a rapid whole blood test for diagnosing H. pylori infection. Br Med J 1997; 314: 119119.
  • 25
    Vaira D, Holton J & Menegatti M, et al. Blood tests in the management of Helicobacter pylori infection. Gut 1998; 43: S3946.
  • 26
    Yuan J-M, Yu M & Xu W-W, et al. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort. Cancer Epidemiol Biomarkers Prev 1999; 8: 6214.
  • 27
    Savarino V, Mela GS & Zentilin P, et al. Comparison of isotope ratio mass spectrometry and nondipersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol 1999; 94: 12038.
    Direct Link:
  • 28
    Cave DR, Zanten SV & Carter E, et al. A multicentre evaluation of the laser assisted ratio analyser (LARA): a novel device for measurement of 13CO2 in the 13C-urea breath test for the detection of Helicobacter pylori infection. Aliment Pharmacol Ther 1999; 13: 74752.DOI: 10.1046/j.1365-2036.1999.00534.x
  • 29
    Minoli G, Prada A & Schuman R, et al. A simplified urea breath test for the diagnosis of Helicobacter pylori infection using the LARA System. Laser Assisted Ratio Analyzer. J Clin Gastroenterol 1998; 26: 2646.